Dapagliflozin (Farxiga)
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Dapagliflozin (Farxiga), covering 2024-06-17 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Dapagliflozin for Anemia in Lower-Risk Myelodysplastic Syndromes [Phase 2]